Turkish Version of Telehealth Satisfaction Survey (TeSS)

December 2, 2023 updated by: Irem Hüzmeli, Mustafa Kemal University

Investigation of the Validity and Reliability of the Turkish Version of Telehealth Satisfaction Survey (TeSS)

The Turkish validity and reliability of the scale, which was created to evaluate the satisfaction of individuals, caregivers, and coordinator providing telerehabilitation services within the scope of telehealth, will be investigated.

Study Overview

Detailed Description

The telehealth satisfaction survey (TeSS) has been developed according to expectations, taking into account a device previously used in telehealth studies in Saskatchewan. The scale was initially used as part of a national study to evaluate the use of telehealth practices in improving professional access by residents of isolated Northern First Nations communities.The scale designed for telehealth services has been developed in English. Validity and reliability studies have been carried out by being translated into various languages. The Turkish validity and reliability study of the scale, originally in English, has not been conducted before.

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Hatay, Merkez, Turkey, 31010
        • Hatay Mustafa Kemal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

telehealth patients caregivers and health professionals who practice telehealth

Description

Inclusion Criteria:

  • Men and woman who used telehealth

Exclusion Criteria:

  • Individuals who have the poor cooperation Mini-Mental State Exam scores of under 23

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
persons who using telehealth (patients)
patients who have received telehealth
Translation and cultural adaptation of the scale will be designed according to the appropriate procedure. Turkish data will be uploaded in the online online method. The scale will be communicated online to those who have received telerehabilitation services, caregivers and healthcare professionals who have applied it. The reliability of the questionnaire will be made by test-retest and internal consistency analysis. Volunteers will be asked to answer the questionnaire online after 5 days. After two weeks, the participants will be asked to answer the questionnaire again with the same method online with 5 days intervals. After all data are collected, validity analysis will be performed
caregivers
family member of the patients who recieved telehealth
Translation and cultural adaptation of the scale will be designed according to the appropriate procedure. Turkish data will be uploaded in the online online method. The scale will be communicated online to those who have received telerehabilitation services, caregivers and healthcare professionals who have applied it. The reliability of the questionnaire will be made by test-retest and internal consistency analysis. Volunteers will be asked to answer the questionnaire online after 5 days. After two weeks, the participants will be asked to answer the questionnaire again with the same method online with 5 days intervals. After all data are collected, validity analysis will be performed
health professions
persons who use the telehealth.
Translation and cultural adaptation of the scale will be designed according to the appropriate procedure. Turkish data will be uploaded in the online online method. The scale will be communicated online to those who have received telerehabilitation services, caregivers and healthcare professionals who have applied it. The reliability of the questionnaire will be made by test-retest and internal consistency analysis. Volunteers will be asked to answer the questionnaire online after 5 days. After two weeks, the participants will be asked to answer the questionnaire again with the same method online with 5 days intervals. After all data are collected, validity analysis will be performed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Turkish Reliability and Validity of TESS (telehealth Satisfaction Survey) for patients, caregivers and health professional who use telehealth
Time Frame: March 2021-April 2022
validation and reliability of survey in Turkish
March 2021-April 2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Irem Huzmeli, PhD, Mustafa Kemal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 12, 2021

Primary Completion (Actual)

May 12, 2022

Study Completion (Actual)

June 12, 2022

Study Registration Dates

First Submitted

March 14, 2021

First Submitted That Met QC Criteria

March 14, 2021

First Posted (Actual)

March 17, 2021

Study Record Updates

Last Update Posted (Actual)

December 5, 2023

Last Update Submitted That Met QC Criteria

December 2, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HatayMKU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Turkish Reliability and Validity of TESS

Subscribe